Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use

Pre-treatment four-digit HLA testing informs on anti-TNF treatment choice and immunomodulator use. In HLA-DQA1*05:01 carriers, adalimumab monotherapy should be used and infliximab avoided. In HLA-DQA1*05:05 carriers, infliximab or adalimumab can be used with a concomitant immunomodulator. In patients who do not carry either HLA-DQA1*05:01 or HLA-DQA1*05:05, adalimumab monotherapy or infliximab with a concomitant immunomodulator are recommended.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-12-17
DOI
https://doi.org/10.1093/ecco-jcc/jjaf233
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use

N Chanchlani, Fagbemi Aa, P M Goggin, Harry Heath et al.
1 citations
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
1.82
article

Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use

N Chanchlani, Fagbemi Aa, P M Goggin, Harry Heath, Simon Panter, Ben Hope, Mary‐Anne Morris, James Goodhand, Cathryn Preston, Charles Murray, Amer Azaz, Gervais Lm, Mowat Ce, Ellen H. Richards, Christopher Roberts, Hasnain Jafferbhoy, Anna J Pigott, Sian Kirkham, Nigel John Trudgill, C Bewshea, Phillip Mayhead, Kevin Monahan, Kevin Lewis, J. Beckly, Mark Tighe, Stephen R. Gore, David Elphick, Mark Smith, Rebecca Saich, Wesley Ed, Richard Shenderey, Croft Nm, Chuka Nwokolo, Amanda Beale, Vinod F. Patel, Phoebe Hodges, Anne M. Willmott, Huw Greenish, Deven Vani, L Grellier, Y. Al-Nuaimi, Tony Chiew Keong Tham, Deb Ghosh, Pollok Rc, Tariq Mahmood, Timothy J. McDonald, F. Martínez Torrente, Andy CY Li, A.T. Cole, Vishal Kaushik, Bruce McLain, Charles PJ Charlton, Triantos Christos, N C Direkze, Zahid Mahmood, Jimmy K Limdi, Helen Matthews, James W Hart, Paul J R Banim, Anjan Dhar, Sandip Sen, Arvind Ramadas, Assad Butt, Stuart L Bloom, J R Fraser Cummings, Thankam Paul, John N Gordon, Richard Johnston, B K Baburajan, Matt W Johnson, Jonathon Snook, Melissa Smith, Claire Bell, John Mansfield, Sheldon C Cooper, Guy Chung-Faye, Andy Bell, Achuth Shenoy, Stephen Bridger, Gareth Jones, John ME Fell, Alison Simmons, Sarah Langlands, Chris Hawkey, Sean Weaver, Timothy Orchard, Stephen M Evans, Daniel R Gaya, John S De Caestecker, Simeng Lin, David Watts, Kasamu Dawa Kabiru, Juan De La Revella Negro, Rakesh Chaudhary, Matthew J Brookes, Rachel Nice, Suranga Dharmisari, Neil Shah, Nicholas A Kennedy, Lawrence Armstrong, Veena Zamvar, Alka Thakur, Radhakrishnan Hariraj, Cathryn Edwards, Rebecca Smith, Alistair McNair, Anita Modi, Subramaniam Ramakrishnan, Richard K Russell, Ailsa Hart, Gill Watts, Neeraj Prasad, Shanika de Silva, Tariq H Iqbal, Bim Bhaduri, Anton V J Gunasekera, Stephen Foley, Marcus Harbord, Martyn Carter, Simon Lal, Rachel Cooney, Senthil Murugesan, Paul Dunckley, Aminda N De Silva, Sonia Bouri, Zia Mazhar, Julie Doherty, Stephen J Lewis, David Hobday, Christian P Selinger, James O Lindsay, Palani Sathish Babu, Anurag Agrawal, Astor Rodrigues, Richard Haigh, Peter M Irving, Mr Richard Miller, Shaji Sebastian, Tariq Ahmad
article en
1 citations

Abstract

Pre-treatment four-digit HLA testing informs on anti-TNF treatment choice and immunomodulator use. In HLA-DQA1*05:01 carriers, adalimumab monotherapy should be used and infliximab avoided. In HLA-DQA1*05:05 carriers, infliximab or adalimumab can be used with a concomitant immunomodulator. In patients who do not carry either HLA-DQA1*05:01 or HLA-DQA1*05:05, adalimumab monotherapy or infliximab with a concomitant immunomodulator are recommended.

Journal of Crohn s and ColitisVol. 20(2)
University of Exeter (GB), University of Cambridge (GB), Royal Devon & Exeter NHS Foundation Trust (GB), Cambridge University Hospitals NHS Foundation Trust (GB)
Good health and well-being
Openalex Percentile: Top 10%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.